Reduction in serum concentrations of ciprofloxacin after administration of ursodiol to a patient with hepatobiliary disease.
Belliveau
P P
PP
Nightingale
C H
CH
Qunitiliani
R
R
Maderazo
E G
EG
D016470:Bacteremia / Q000097:blood* / Q000188:drug therapy / Q000382:microbiology; D001660:Biliary Tract Diseases / Q000097:blood* / Q000188:drug therapy / Q000382:microbiology; D002939:Ciprofloxacin / Q000097:blood* / Q000627:therapeutic use; D004347:Drug Interactions; D006801:Humans; D007710:Klebsiella Infections / Q000097:blood* / Q000150:complications / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D014580:Ursodeoxycholic Acid / Q000008:administration & dosage*
D002939:Ciprofloxacin; D014580:Ursodeoxycholic Acid